In order to optimize your KOL Identification and Outreach plan, our team will develop a map of potential influencers across Academic Hospitals and Large Community Oncology Practices with the potential to act as champions for your product in support of increased access for patients through a quantitative peer-nomination process.
As a first step, our expert team will conduct secondary research to understand provider reach, including completion of a medical literature review to identify influential publishers and a review of CME events/major conferences to identify influential speakers/presenters with expertise and influence in disease and who have the capacity to impact access, coverage, and reimbursement for the product in support of increased access for patients through a quantitative peer-nomination process.
Following the secondary research, identified HCPs will be validated through primary market research quantitative interviews to execute the peer-nomination process to identify key influencers and opinion leaders in the disease, specifically as it relates to access for your product.
